filmov
tv
Exploring Renal Cell Carcinoma Research: Expert Insights on Immunotherapy and Targeted Therapy
Показать описание
What’s important in renal cell carcinoma research news? Expert Dr. Moshe Ornstein from Cleveland Clinic shares an overview of research updates on immunotherapy, targeted therapy, and combination therapies.
Exploring Renal Cell Carcinoma Research: Expert Insights on Immunotherapy and Targeted Therapy
Rini Explores PD-1 Inhibition in Renal Cell Carcinoma
Exploring MEDI0680/Durvalumab Versus Nivolumab in Metastatic ccRCC
Checkpoint Inhibitors Under Exploration in RCC
Exploring the Combination of First-Line Avelumab/Axitinib in HCC
PD-1 Combinations Explored in RCC
Immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: ASCO GU 2023
KCRS24 - Biotech Showcase on Emerging Therapies for Kidney Cancer | KidneyCAN
Exploring therapeutic targets in RA | Dr Gerd Burmester
Dr. Pal on Molecular Signatures in Renal Cell Carcinoma
Exploring Cabozantinib With Nivolumab and Ipilimumab in Urothelial Carcinoma
AGILE Trial: Frontline Axitinib Versus Sorafenib in Metastatic Renal Cell Carcinoma
KCRS22 Session Four: Clinical Trials in Progress at the Kidney Cancer Research Summit
Network Exploration for Cancer Research Webinar.
A novel CXCR4 inhibitor for RCC and a novel immunotherapy endpoint | David McDermott
Treatment of Metastatic Non-Clear Cell Renal Cell Carcinoma
KCRS24 Session One: Exploring Novel Drug Targets for RCC
CCLG Research Talks - Episode 1: How Kidney Cancer Research Works
Other Trials of Interest in Renal Cancers
Renal Cell Carcinoma
Risk Stratification in Metastatic Renal Cell Carcinoma
Overview of a Phase III Trial of Pembrolizumab Plus Axitinib in RCC
Biomarkers in Kidney Cancer: Session One - KCRS23 | KidneyCAN
